HIGH-RESOLUTION MASS-SPECTROMETRY-BASED PROTEOMICS AND FUNCTIONAL VALIDATION REVEALED DISTINCT THERAPEUTIC CAPABILITIES RELATED TO DIFFERENT PRIMING STRATEGIES IN MESENCHYMAL STROMAL/STEM CELLS: POTENTIAL IMPLICATIONS FOR THEIR CLINICAL

被引:0
|
作者
Miceli, V. [1 ]
Scilabra, S. D. [2 ]
Calligaris, M. [2 ]
Zito, G. [1 ]
Busa, R. [1 ]
Gallo, A. [1 ]
Bulati, M. [1 ]
Conaldi, P. [1 ]
机构
[1] IRCCS ISMETT Istituto Mediterraneo Trapianti Tera, Res Dept, Palermo, Italy
[2] IRCCS ISMETT Istituto Mediterraneo Trapianti Tera, Res Dept, Prote Grp Fdn, Ri MED, Palermo, Italy
关键词
Mesenchymal stromal/stem cells; Priming; Advanced Therapy Medicinal Products;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
176
引用
收藏
页码:S73 / S74
页数:2
相关论文
共 2 条
  • [1] Different priming strategies improve distinct therapeutic capabilities of mesenchymal stromal/stem cells: Potential implications for their clinical use
    Miceli, Vitale
    Zito, Giovanni
    Bulati, Matteo
    Gallo, Alessia
    Busa, Rosalia
    Iannolo, Gioacchin
    Conaldi, Pier Giulio
    WORLD JOURNAL OF STEM CELLS, 2023, 15 (05): : 400 - 420
  • [2] Proteomic analysis and functional validation reveal distinct therapeutic capabilities related to priming of mesenchymal stromal/stem cells with IFN-γ and hypoxia: potential implications for their clinical use
    Calligaris, Matteo
    Zito, Giovanni
    Busa, Rosalia
    Bulati, Matteo
    Iannolo, Gioacchin
    Gallo, Alessia
    Carreca, Anna Paola
    Cuscino, Nicola
    Castelbuono, Salvatore
    Carcione, Claudia
    Centi, Claudio
    Amico, Giandomenico
    Bertani, Alessandro
    Chinnici, Cinzia Maria
    Conaldi, Pier Giulio
    Scilabra, Simone Dario
    Miceli, Vitale
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12